Fortune Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 10.00 Cr
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 33.24 Cr
- Satisfied Charges ₹ 21.58 Cr
About Fortune Pharma
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2002PTC136393
-
Company No.
136393
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jul 2002
-
Date of AGM
30 Sep 2013
-
Date of Balance Sheet
31 Mar 2013
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Fortune Pharma?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sudhakar Mulay
![]() |
Managing Director | 02-Jul-2002 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishram Jagtap
![]() |
Director | 02-Jul-2002 | Current |
Vikram Mulay
![]() |
Director | 02-Jul-2002 | Current |
Financial Performance of Fortune Pharma.
Enhance accessibility to Fortune Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Fortune Pharma?
Unlock access to Fortune Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹33.24 Cr
₹21.58 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 33.16 Cr
- Punjab National Bank : 0.08 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Nov 2012 | State Bank Of India | ₹16.16 Cr | Open |
30 Mar 2011 | State Bank Of India | ₹17.00 Cr | Open |
11 Dec 1982 | Punjab National Bank | ₹0.80 M | Open |
29 Dec 2006 | Canara Bank | ₹5.44 Cr | Satisfied |
29 Mar 2005 | Canara Bank | ₹16.14 Cr | Satisfied |
How Many Employees Work at Fortune Pharma?
Fortune Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Fortune Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Pharma's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.